Stockreport

Nkarta to Participate in November Investor Conferences

Nkarta, Inc.  (NKTX) 
PDF SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural ki [Read more]